MELOMANES - Combination therapy for the treatment of metastatic melanoma using magnetic nanoparticles

Datos básicos

Código:
EU21/30
Dotación:
251.971,20 EUR
Año Inicial:
2023
Año final:
2027
PROYECTO Investigación cooperativa EUROPEA Subvención

Objetivos del proyecto

MELOMANES aims to train doctoral researchers for the development of a combined therapy exploiting the properties of magnetic nanoparticles to induce damage on the tumor microenvironment by magnetic and optic hyperthermia in order to facilitate the infiltration of CAR-T cells. This therapeutic approach combining hyperthermia and immunotherapy is versatile, as it could be also applied to other types of solid tumors. Research and transferable training of the doctoral researchers will be performed in a highly interdisciplinary, intersectoral, and international environment. In addition to acquiring skills related to the research project, they will be trained also in open science, communication and dissemination, responsible research and innovation, circular economy, ethics, data management, entrepreneurship, marketing, intellectual property, and gender dimension in research.

Unidades de investigación

Documentos

  • No hay documentos

Participantes

Financiadores

COMISIÓN EUROPEA

Compartir